Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Marieke H. Roozeboom"'
Autor:
Lieke C.J. van Delft, Patty J. Nelemans, Janneke P.H.M. Kessels, Hilke Kreukels, Marieke H. Roozeboom, Michette J.M. de Rooij, Klara Mosterd, Ellen R.M. de Haas, Nicole W.J. Kelleners-Smeets
Publikováno v:
Dermatology, 238(6), 1044-1049. Karger
Dermatology, 238(6), 1044-1049. S. Karger AG
Dermatology, 238(6), 1044-1049. S. Karger AG
Background: Photodynamic therapy (PDT) is a noninvasive treatment for patients with superficial basal-cell carcinoma (sBCC). The efficacy of PDT may vary with different photosensitizers and treatment schedules. Objective: Our objective was to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35e3729895a9b93a0a70cd96efff4621
https://pure.eur.nl/en/publications/9053fad1-9a02-46bb-9f84-2d3b7b260688
https://pure.eur.nl/en/publications/9053fad1-9a02-46bb-9f84-2d3b7b260688
Autor:
Maud H.E. Jansen, Klara Mosterd, Aimee H.M.M. Arits, Fabienne H.J. Koekelkoren, Nicole W.J. Kelleners-Smeets, Marieke H. Roozeboom, Patty J. Nelemans
Publikováno v:
Journal of the American Academy of Dermatology, 79(5), 961-964. MOSBY-ELSEVIER
Autor:
Marieke H. Roozeboom, Anja Sommer, Nicole W.J. Kelleners-Smeets, Han P. A. van Pelt, Brigitte A. B. Essers, Maud H.E. Jansen, Patricia J. F. Quaedvlieg, P.M. Steijlen, Aimee H.M.M. Arits, Patty J. Nelemans, Klara Mosterd
Publikováno v:
Journal of Investigative Dermatology, 138(3), 527-533. Elsevier Science
For the treatment of superficial basal cell carcinoma, a prospective, noninferiority, randomized controlled multicenter trial with 601 patients showed that 5% imiquimod cream was superior and 5-fluorouracil cream not inferior to methyl aminolevulinat
Autor:
Brigitte A. B. Essers, Aimee H.M.M. Arits, Klara Mosterd, Patricia J. F. Quaedvlieg, Michette J. M. De Rooij, Patty J. Nelemans, Marieke H. Roozeboom, P.M. Steijlen, Anja Sommer, Nicole W.J. Kelleners-Smeets
Publikováno v:
Journal of Investigative Dermatology, 136(8), 1568-1574. Elsevier Science
A randomized controlled trial including 601 patients previously showed that the effectiveness of imiquimod and fluorouracil cream were not inferior to methyl aminolevulinate photodynamic therapy (MAL-PDT) in patients with superficial basal cell carci
Autor:
Klara Mosterd, Aimee H.M.M. Arits, Lieke C.J. van Delft, Myrurgia Abdul Hamid, Patty J. Nelemans, Maud H.E. Jansen, Nicole W.J. Kelleners-Smeets, Marieke H. Roozeboom
Publikováno v:
Journal of the American Academy of Dermatology, 80(4), 1022-1028. MOSBY-ELSEVIER
Background: There have been concerns that recurrences after noninvasive therapy for basal cell carcinoma (BCC) transform into a "more aggressive'' histologic subtype.Objective: We sought to evaluate the proportion of patients with a nonsuperficial tr
Autor:
Patty J. Nelemans, Marieke H. Roozeboom, Nicole W.J. Kelleners-Smeets, Aimee H.M.M. Arits, Klara Mosterd, P.M. Steijlen
Publikováno v:
British Journal of Dermatology, 172(3), 739-745. Wiley
Background A recent noninferiority randomized controlled trial (RCT) indicated that imiquimod can be considered as superior to methylaminolevulinate photodynamic therapy (MAL-PDT) in the treatment of superficial basal cell carcinoma (sBCC). Knowledge
Autor:
Nicole W.J. Kelleners-Smeets, Ariënne M W van Marion, Bjorn G.P.M. Lohman, Annet Westers-Attema, Patty J. Nelemans, Valerie M H J Joosten, P.M. Steijlen, Anita A Botterweck, Marieke H. Roozeboom
Publikováno v:
Acta Dermato-Venereologica, 95(2), 181-185. Society for the Publication of Acta Dermato-Venereologica
Diagnosis and subsequent treatment of cutaneous squamous cell carcinoma are frequently based on punch biopsies. Regarding the current TNM classification and stage grouping for cutaneous squamous cell carcinoma, it is important to identify the high-ri
Autor:
J.P.H.M. Kessels, Patty J. Nelemans, Klara Mosterd, H. van Pelt, Nicole W.J. Kelleners-Smeets, Marieke H. Roozeboom, E.R.M. de Haas, H. Kreukels
Publikováno v:
British Journal of Dermatology, 178(5), 1056-1063. Wiley-Blackwell Publishing Ltd
British Journal of Dermatology, 178(5), 1056-1063. Wiley
British Journal of Dermatology, 178(5), 1056-1063. Wiley
Background Basal cell carcinoma (BCC) is the most common type of skin cancer and incidence rates are increasing. Photodynamic therapy (PDT) is a frequently used treatment, especially for superficial BCC (sBCC). Two topical photosensitizing agents are
Autor:
Gertruud A. M. Krekels, Klara Mosterd, Nicole W.J. Kelleners-Smeets, H. A. Martino Neumann, Patty J. Nelemans, Marieke H. Roozeboom, Carmen D. Dirksen, Eva van Loo, P.M. Steijlen, Judith U. Ostertag
Publikováno v:
European Journal of Cancer, 50(17), 3011-3020. Elsevier Ltd.
European Journal of Cancer, 50(17), 3011-3020. ELSEVIER SCI LTD
European Journal of Cancer, 50(17), 3011-3020. ELSEVIER SCI LTD
Background: Basal cell carcinoma (BCC) is the most common form of cancer among Caucasians and its incidence continues to rise. Surgical excision (SE) is considered standard treatment, though randomised trials with long-term follow-up are rare. We now
Autor:
Patty J. Nelemans, Danielle I.M. Kuijpers, Klara Mosterd, Marieke H. Roozeboom, Monique R. T. M. Thissen, Martine A. Aardoom, Nicole W.J. Kelleners-Smeets
Publikováno v:
Journal of the American Academy of Dermatology, 69(2), 280-287. MOSBY-ELSEVIER
Background: Although effective in superficial basal cell carcinoma (BCC), the treatment effect of photodynamic therapy (PDT) in nodular BCC (nBCC) is still questionable. The relation between tumor thickness and PDT failure is unclear. Objective: We s